Advance Notice: EastPharma Ltd Sales Update Announcement for the period 31 March 2016
EASTPHARMA LTD.
London, 25 April 2016 - EastPharma (EAST LI) informs that it will be releasing its Q1 2016 sales performance and a review of its main subsidiary DEVA Holding's unaudited financial statements for the related period on 5 May 2016.
A conference call to review the Q1 2016 sales performance will be hosted by the management of EastPharma at 12:00-noon London time on 6 May 2016 (07:00am New York / 01:00pm Zurich time / 02:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): + 44 (0)207 1620 177
Dial-in Number (US): + 1 334 323 6203
Dial-in Number (Switzerland): + 41 (0)434 5692 63
Dial-in Number (Germany): + 49 (0)695 8999 0509
Conference ID: 958508
For further information, please contact:
Investor Relations:
email:
ir@eastpharma.com
EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit www.eastpharma.com .
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: EastPharma Ltd via GlobeNewswire
